Oct 01, 2021 · Hypercoagulable state, secondary; Thrombophilia; ICD-10-CM D68.69 is grouped within Diagnostic Related Group(s) (MS-DRG v 39.0): 814 Reticuloendothelial and immunity disorders with mcc; 815 Reticuloendothelial and immunity disorders with cc; 816 Reticuloendothelial and immunity disorders without cc/mcc; Convert D68.69 to ICD-9-CM. …
What is the ICD 10 code for hypercoagulable? D68. 69 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D68. 69 became effective on October 1, 2021. What is the ICD 10 code for secondary hypercoagulable state? 289.82 – Secondary hypercoagulable state | ICD-10-CM.
289.82 - Secondary hypercoagulable state. 289.82 - Secondary hypercoagulable state is a topic covered in the ICD-10-CM. To view the entire topic, please log in or purchase a subscription. ICD-10-CM 2022 Coding Guide™ from Unbound Medicine. Search online 72,000+ ICD-10 codes by number, disease, injury, drug, or keyword.
289.82 Secondary hypercoagulable state 427.31 A-fib ICD-10 Codes: D68.69 Other thrombophilia I48.2 Chronic A-fib Plan: Check INR in 2 days. OR Assessment: Mechanical mitral valve replacement on Coumadin. ICD-9 Code: V43.3 Heart Valve replaced by other means ICD-10 Code: Z95.2 Presence of prosthetic heart valve ICD-9 Code: V58.61 Long-term (current) use of …
Secondary hypercoagulable states are generally acquired disorders in patients with underlying systemic diseases or clinical conditions such as pregnancy or use of oral contraceptives that are known to be linked to an increased risk of thrombosis.
D68. 69 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D68. 69 became effective on October 1, 2021.
Hypercoagulable states are usually genetic (inherited) or acquired conditions. The genetic form of this disorder means a person is born with the tendency to form blood clots.Apr 25, 2019
Diagnosis of hypercoagulability can include blood tests to look at the levels of anticoagulant proteins, as well as genetic testing to identify the most common inherited thrombophilias.
E78.5ICD-10 | Hyperlipidemia, unspecified (E78. 5)
ICD-10 | Hyperkalemia (E87. 5)
Based on current knowledge, antiphospholipid syndrome is the most prevalent hypercoagulable state, followed by factor V Leiden (FVL) mutation, prothrombin gene G20210A mutations, elevated factor VIII, and hyperhomocysteinemia.
A hypercoagulable or prothrombotic state of malignancy occurs due to the ability of tumor cells to activate the coagulation system. It has been estimated that hypercoagulation accounts for a significant percentage of mortality and morbidity in cancer patients.
Examples of conditions that can cause secondary hypercoagulable states are atrial fibrillation, malignancy, pregnancy, trauma, myeloproliferative disorders, and antiphospholipid antibody syndrome.
Factor V Leiden mutation—this is the most common inherited factor associated hypercoagulopathy
Malignancy—coders see this often documented as the cause of thrombosis. These malignancies are either known or occult
So, now that we know a little more about what a hypercoagulable state is, let’s look at some of the coding concerns that may arise.
The information contained in this coding advice is valid at the time of posting. Viewers are encouraged to research subsequent official guidance in the areas associated with the topic as they can change rapidly.